CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Grant or award Director acquired 6,865 shares (grant or award)
- 4 Grant or award Director acquired 6,865 shares (grant or award)
- 4 Grant or award Director acquired 6,865 shares (grant or award)
- 4 Shares withheld for taxes SVP & CFO gave up 4,534 shares (to pay taxes)
- 4 Shares withheld for taxes SVP OPS & PROD DEV gave up 2,289 shares (to pay taxes)
- 4 Grant or award SVP & CFO acquired 40,526 shares (grant or award)
- 4 Grant or award PRESIDENT & CEO acquired 159,216 shares (grant or award)
- 4 Grant or award HEAD OF R&D, COO-NOVITIUM OPS acquired 28,947 shares (grant or award)
- 4 Grant or award HEAD OF RARE DISEASE acquired 28,947 shares (grant or award)
- 4 Grant or award SVP OPS & PROD DEV acquired 21,710 shares (grant or award)
- 4 Grant or award SVP, GENERICS acquired 28,947 shares (grant or award)
- 4 Grant or award SVP - CORP. DEV. & STRATEGY acquired 28,947 shares (grant or award)
- 4 Grant or award SVP, CHIEF HR OFFICER acquired 20,262 shares (grant or award)
- 4 Grant or award SR. VP, GENERAL COUNSEL & SEC. acquired 20,262 shares (grant or award)
- 4 Shares withheld for taxes SVP OPS & PROD DEV gave up 524 shares (to pay taxes)
- 4 Shares withheld for taxes SVP AND CFO gave up 1,420 shares (to pay taxes)
- 4 Shares withheld for taxes SVP OPS & PROD DEV gave up 2,452 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT & CEO gave up 17,455 shares (to pay taxes)
- 4 Shares withheld for taxes SVP AND CFO gave up 4,224 shares (to pay taxes)
- 4 Shares withheld for taxes HEAD OF RARE DISEASE gave up 1,902 shares (to pay taxes)
Page 14 of 42 · 835 filings